https://pubs.rsc.org/en/content/articlelanding/2021/sc/d1sc02725e
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic...
The development of new antibiotics is imperative to fight increasing mortality rates connected to infections caused by multidrug-resistant (MDR) bacteria. In...
broad spectrumimprovedantibiotics